Healthcare & Life Sciences Business Grants
The UK life sciences sector benefits from substantial government investment through UKRI, NHS innovation programmes, and dedicated biotech funding. Grants support research, development, and commercialisation of healthcare innovations.
Medical Research Funding
UKRI, MRC, and charity funders support biomedical research and early-stage development. Academic-industry partnerships can access significant research grant funding.
NHS Innovation
NHS programmes including SBRI Healthcare and Academic Health Science Networks support health tech companies to develop and deploy innovations within the healthcare system.
Regulatory & Commercialisation
Grants help life sciences companies navigate regulatory approval and commercialisation. This includes clinical trial support and market access assistance.
US Life Sciences & Health Grants
201 grants found
U.S. National Institutes of Health Grants
The NIH is currently funding grant opportunities related to COVID-19 research.
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
The National Institutes of Health is accepting applications for grants to support cancer intervention and surveillance modeling.
Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
The National Institutes of Health is accepting applications for grants to support clinical trials in somatic cell genome editing.
Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
The National Institutes of Health is accepting applications for grants to support the reuse of data assets.
Massachusetts Next Generation Initiative (MassNextGen)
A competitive program that awards women-led early-stage life science companies a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned Executive Coaches from the life sciences ecosystem to refine their business strategies and effectively raise capital.
Life Sciences NIIMBL
Accelerates biopharmaceutical manufacturing innovation, supports the development of standards that enable more efficient and rapid manufacturing capabilities, and educates and trains a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.
Building Breakthroughs (Biomanufacturing)
Provides grants for capital projects that support biomanufacturing innovation, including improvements to upstream/downstream processing, production of cell and gene therapies, monoclonal antibodies, and small molecules, quality and safety, and storage/stability, in the Commonwealth.
Novel Therapeutics Delivery
Aims to foster the development of novel technologies and techniques for the delivery of existing or innovative therapies by working at the intersection of engineering, biology, chemistry, and medicine.
Women's Health
Supports collaborative projects that aim to improve the discovery, technical innovation, and/or analysis of datasets to answer pressing life science questions around women’s health.
Bits to Bytes
Provides grants for scientific projects that generate and analyze large datasets to answer pressing life science questions, and to attract and train data scientists in the Commonwealth.
Life Sciences Tax Incentives
The Tax Incentive program is offered to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts.
Research Infrastructure Program
Provides grants for capital projects that support the life sciences ecosystem in Massachusetts by enabling and supporting life sciences research and development in the Commonwealth.
Frequently Asked Questions
Common questions about US life sciences & health grants